Matthew Britt, DPM
Foot & Ankle Surgery · Rockwall, TXNPI 1104164896
Payments from drug & device makers
Across 818 payments — averaging $125.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$44K
- Eminent Spine, LLC$27K
- Anika Therapeutics, Inc.$13K
- Smith+Nephew$10K
- Stryker$2K
- Amgen$2K
- plus $6K from 31 others
What the payments were for
- Consulting fees$73,88872%
- Speaking & faculty fees$5,5755%
- Travel & lodging$5,0315%
- Food & beverage$17,23417%
- Education$7021%
- Gifts$1510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 293 | $43,565 |
| Eminent Spine, LLC | 3 | $27,040 |
| Anika Therapeutics, Inc. | 18 | $12,637 |
| Smith+Nephew | 141 | $9,518 |
| Stryker(2 entities) | 105 | $2,331 |
| Amgen(2 entities) | 150 | $1,712 |
| Vilex LLC | 2 | $1,087 |
| 4web, Inc. | 4 | $990 |
| Paragon 28, Inc. | 5 | $891 |
| Pylant Medical | 6 | $840 |
| Sandoz | 19 | $290 |
| Abbott | 4 | $239 |
| Paratek Pharmaceuticals, Inc. | 10 | $165 |
| Bioventus LLC | 9 | $157 |
| Orthofix Medical, Inc. | 5 | $148 |
| Johnson & Johnson | 5 | $147 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $102 |
| Ossio Inc | 1 | $88 |
| Normatec Industries, LP | 4 | $76 |
| Treace Medical Concepts, Inc. | 4 | $73 |
| Organogenesis Inc. | 4 | $68 |
| In2bones USA, LLC | 1 | $61 |
| Nabriva Therapeutics, PLC | 3 | $50 |
| Medshape, Inc. | 1 | $48 |
| Biotissue Holdings Inc. | 2 | $37 |
| Axogen | 2 | $31 |
| Kerecis Limited | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Solventum Corporation | 1 | $21 |
| Acumed LLC | 1 | $20 |
| KCI USA, Inc. | 1 | $18 |
| Access Pro Medical, LLC | 1 | $17 |
| Nevro Corp. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Glenmark Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Eminent Foot Plate Systems$27,000
- INTEGRA$24,484
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$16,362
- CADENCE ANKLE REPLACEMENT SYSTEM$13,287
- PANTA NAIL$13,287
- TOTAL FOOT SYSTEM$13,287
- TACTOSET$12,451
- INTEGRA WOUND MATRIX (IWM)$9,025
- BILAYER WOUND MATRIX (BWM)$7,275
- IDRT$7,275
- FLOWABLE$7,275
- Panta 2$6,175
- Cadence$5,521
- ADVANCED WOUND CARE$3,313
- Peri-Loc$3,075
- Integra XT$3,075
- NEURAGEN$2,450
- HALLU-LOCK$1,887
- INTEGRA MESHED BILAYER WOUND MATRIX$1,750
- SURGIMEND$1,750
How this compares
$102,581 in reported general payments places this provider in the 90th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 15 | $13,147 |
| Nystatin | 90 | $8,034 |
| Econazole Nitrate | 162 | $3,621 |
| SantylCollagenase Clostridium Hist. | 12 | $3,552 |
| Gabapentin | 258 | $2,093 |
| Ammonium Lactate | 61 | $1,973 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 118 | $1,603 |
| Diclofenac Sodium | 17 | $1,562 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 12 | $1,342 |
| Mupirocin | 133 | $1,263 |
| Colchicine | 23 | $781 |
| Doxycycline Monohydrate | 51 | $686 |
| Pregabalin | 58 | $677 |
| Terbinafine Hcl | 51 | $618 |
| Doxycycline Hyclate | 46 | $568 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $102 | $13,14715 claims |
| Smith+NephewSantyl | $9,518 | $3,55212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 684 foot & ankle surgery providers in Texas.
Other foot & ankle surgery in Rockwall
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$972K
- Mark RobsonAustin$957K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.